EQUIL93: a tool for experimental and clinical urolithiasis.
An extensively updated version of the EQUIL software is described. The former version, designated EQUIL2, is widely used to study urolithiasis and related areas of biomineralization. In this report, we discuss recent enhancements which give EQUIL93 an expanded scope of application. This program has been frequently used in studies of the physicochemical processes underlying stone salt crystallization, especially crystal growth and nucleation, but it has also been employed as an aid for in vivo research and as an evaluator of therapeutic measures. We illustrate several new applications, including some outside the urologic realm, and we discuss how the enhanced software can be helpful in stone risk assessments.